Variability of low-molecular-weight serum subproteome in healthy humans under the conditions of normal vital activity

Human Physiology

Volumn 37, Issue 2, 2011, Pages 193-199

  Pakharukova, N A ^a   Pastushkova, L Kh ^a   Trifonova, O P ^a   Moshkovskii, S A ^b   Larina, I M ^a  

^a INSTITUTE OF BIOMEDICAL PROBLEMS   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

mass spectrometry based profiling; proteome of a healthy man; proteomics; variability

Indexed keywords

EID: 79954536540     PISSN: 03621197     EISSN: 16083164     Source Type: Journal    
DOI: 10.1134/S0362119711020149     Document Type: Article

References (37)

1. Zhang, X., Guo, Y., Song, Y., et al., Proteomic Analysis of Individual Variation in Normal Livers of Human Beings Using Difference Gel Electrophoresis, Proteomics, 2006, vol. 6(19), p. 5260.
2. Chen, R., Pan, S., Brentnall, T. A., et al., Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery, Mol. Cell. Proteom., 2005, vol. 4, no. 4, p. 523.
3. Nelsestuen, G. L., Zhang, Y., Martinez, M. B., et al., Plasma Protein Profiling: Unique and Stable Feature of Individuals, Proteomics, 2005, no. 5, p. 4012.
4. Anderson, N. L. and Anderson, N. G., The Human Plasma Proteome: History, Character, and Diagnostic Prospects, Mol. Cell. Proteom., 2002, vol. 1, no. 11, p. 845.
5. Linkowski, P., Spiegel, K., Kerkhofs, M., et al., Genetic and Environmental Influences on Prolactin Secretion during Wake and during Sleep, Am. J. Physiol., 1998, vol. 274, p. 909.
6. Grigor'ev, A. I. and Baevskii, R. M., Kontseptsiya zdorov'ya i problema normy v kosmicheskoi meditsine (Concept of Health and Norm Problem in Space Medicine), Moscow: Slovo, 2001.
7. Anderson, N. L., Polanski, M., Pieper, R., et al., The Human Plasma Proteome: a Nonredundant List Developed by Combination of Four Separate Sources, Mol. Cell. Proteom., 2004, vol. 3, no. 4, p. 11.
8. Villanueva, J., Shaffer, D. R., Philip, J., et al., Differential Exopeptidase Activities Confer Tumor-Specific Serum Peptidome Patterns, J. Clin. Invest., 2006, vol. 116, no. 1, p. 271.
9. Lopez, M. F., Mikulskis, A., Kuzdzal, S., et al., A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples, Clin. Chem., 2007, vol. 53, no. 6, p. 1067.
10. Allard, L., Lescuyer, P., Burgess, J., et al., Apo C-I, and Apo C-III As Potential Plasmatic Markers to Distinguish between Ischemic and Hemorrhagic Stroke, Proteomics, 2004, vol. 4, no. 8, p. 2242.
11. Tammen, H., Hess, R., Shulte, I., et al., Prerequisites for Peptidomic Analysis of Blood Samples: II. Analysis of Human Plasma After Oral Glucose Challenge-a Proof of Concept, Comb. Chem. High Throughput Screen, 2005, vol. 8, no. 8, p. 735.
12. Vermeulen, R., Lan, Q., Zhang, L., et al., Decreased Levels of CXC-Chemokines in Serum of Benzene Exposed Workers Identified by Array-Based Proteomics, Proc. Natl. Acad. Sci. the USA, 2005, vol. 102(47), p. 1704.
13. Nomura, F., Tomonaga, T., Sogawa, K., et al., Identification of Novel and Downregulated Biomarkers for Alcoholism by Surface Enhanced Laser Desorption/Ionization Mass-Spectrometry, Proteomics, 2004, no. 4, p. 1187.
14. Ward, D. G., Cheng, Y., N'Kontchou, G., et al., Changes in the Serum Proteome Associated with the Development of Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis, Br. J. Cancer, 2006, vol. 94, p. 287.
15. Bondarenko P. V., Cocarill, S. L., Watkins, L. K., et al., Mass-Spectral Study of Polymorphism of Apolipoprotein of Very Low-Density Lipoproteins, J. Lipid Res., 1999, vol. 40. no. 3, p. 543.
16. Zinkin, N. T., Grall, F., Bhaskar, K., Otu, H. H., et al., Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease, Clin. Cancer Res., 2008, vol. 14, no. 2, p. 470.
17. Orvisky, E., Drake, S. K., Martin, B. M., et al., Enrichment of Low Molecular Weight Fraction of Serum for MS Analysis of Peptides Associated with Hepatocellular Carcinoma, Proteomics, 2006, vol. 6, no. 9, p. 2895.
18. Ferreira, S. H. and Vane, J. R., The Disappearance of Bradykinin and Eledoisin in the Circulation and Vascular Beds of the Cat, Br. J. Pharmacol. Chemother., 1967, vol. 30, no. 2, p. 417.
19. Murphey, L. J., Hachey, D. L., Oates, J. A., et al., Metabolism of Bradykinin in vivo in Humans: Identification of BK1-5 As a Stable Plasma Peptide Metabolite, J. Pharmacol. Exp. Therap., 2000, vol. 294, no. 1, p. 263.
20. Pak, S. G., Infektsionnye bolezni: vzglyad cherez prizmu vremeni. Aktovaya rech'. (Infectious Diseases: A Glance through the Prism of Time), Moscow, GOU, 2005.
21. Voronin, E. S., Petrov, A. M., and Serykh, M. M., Immunologiya, (Immunology), Moscow: Kolos-Press, 2002.
22. Yarovaya, G. A., Bioregulatory Functions and Pathogenetic Role of Proteolysis, Lab. Med., 2000, no. 3, p. 19.
23. Korolenko, T. A., Filatova, T. G., Yuz'ko, Yu. V., et al., Cystatin C: Biological Role and secretion disorders in Virus Hepatitis and Hepatic Cirrhosis, Klin. Lab. Diagn., 2007, no. 12, p. 18.
24. Aleshkin, V. A., Novikova, L. I., Lyutov, A. G., et al., Acute Phase Proteins and Their Clinical Meanings, Klin. Med., 1998, no. 8, p. 39.
25. Severin, E. S., Aleinikova, T. L., and Osipov, E. V., Biokhimiya, (Biochemistry), Moscow: Meditsina, 2000.
26. Mahley, R. W., Innerarity, T. L., Rall, S. C., et al., Plasma Lipoproteins: Apolipoprotein Structure and Function, J. Lipid Res., 1984, vol. 25, no. 12, p. 1277.
27. Mitchell, B. L., Yasu, Y., Lampe, J. W., et al., Evaluation of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry Proteomic Profiling: Identification of β2-HSglycoprotein B-Chain As a Biomarker of Diet, Proteomics, 2005, vol. 5, p. 2238.
28. Rossi, L., Martin, B., Hortin, G. L., et al., Inflammatory Protein Profile during Systemic High Dose Interleukin-2 Administration, Proteomics, 2006, vol. 6. no. 2, p. 709.
29. Hu, Y., Malone, J. P., Fagan, A. M., et al., Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid, Mol. Cell. Proteom., 2005, vol. 4. no. 12, p. 2000.
30. Winkler, W., Zellner, M., Diestinger, M., et al., Biological Variation of the Platelet Proteome in the Elderly Population and Its Implication for Biomarker Research, Mol. Cell. Proteom., 2008, vol. 7, no. 1, p. 193.
31. Corzett, T. H., Fodor, I. K., Choi, M. W., et al., Statistical Analysis of Variation in the Human Plasma Proteome, J. Biomed. Biotechnol., 2010.
32. Voshol, H., Glucksman, M. J., and van Oostrum, J., Proteomics in the Discovery of New Therapeutic Targets for Psychiatric Disease, Curr. Mol. Med., 2003, vol. 3, no. 5, p. 447.
33. Goncalves, A., Esterni, B., Bertucci, F., et al., Postoperative Serum Proteomic Profiles May Predict Metastatic Relapse in High-Risk Primary Breast Cancer Patients Receiving Adjuvant Chemotherapy, Oncogen, 2006, vol. 25, no. 7, p. 981.
34. Marshall, J., Kupchak, P., Zhu, W., et al., Processing of Serum Proteins Underlies the Mass Spectral Fingerprinting of Myocardial Infarction, J. Proteome Res., 2003, vol. 2, no. 4, p. 361.
35. Macy, E. M., Hayes, T. E., and Tracy, R. P., Variability in the Measurement of C-Reactive Protein in Healthy Subjects: Implications for Reference Intervals and Epidemiological Applications, Clin. Chem., 1997, vol. 43, no. 1, p. 52.
36. Clark, G. H. and Fraser, C. G., Biological Variation of Acute Phase Proteins, Ann. Clin. Biochem., 1993, vol. 39, no. 4, p. 373.
37. Huguet, J. and Fuentes-Arderiu, X., Biological Variation in the Catalytic Concentration of Pancreatic Alpha-Amylase and Triacylglycerol Lipase in Serum, Scand. J. Clin. Lab. Invest., 1991, vol. 51, no. 8, p. 735.